Abstract

Background: Cervical cancer is a common malignant tumor in women worldwide. Screening for early detection of cervical cancer is the best method to detect abnormalities. Recently, cervical cancer screening test kits using the liquid-based cytology method, including Thinprep Pap, have been approved by the US Food and Drug Administration (FDA).

Objectives: 1) To determine the rates of precancerous lesions and cervical cancer based on the classification of the Bethesda system (2014). 2) To assess the relationship between precancerous lesions and cervical cancer with general and clinical characteristics.

Method: Cross-sectional, prospective, and retrospective study on 502 patients undergoing cytological diagnosis using Thinprep Pap technique at Hue University of Medicine and Pharmacy hospital.

Results: Thinprep Pap method results in screening and detecting lesions of 6.4% (ASCUS (1.6%), LSIL (1.6%), ASC-H (2,0%), HSIL (0.2%), AGC (0.8%), SCC (0.2%), adenocarcinoma (0%).

Conclusion: Thinprep Pap technique is effective in screening precancerous lesions and cervical cancer. There is a statistically significant association between precancerous lesions and cervical cancer with area and clinical diagnosis.